Europe — EMA
Liprolog Junior Kwikpen
GNH USA supplies Liprolog Junior Kwikpen (Insulin Lispro), a rapid‑acting insulin analog for Type 1 and Type 2 diabetes. Request a quote for quick supply.
Request sourcing
What is Insulin Lispro?
Insulin Lispro, the active ingredient in Liprolog Junior Kwikpen, is a rapid‑acting insulin analog presented as a solution for injection (pre‑filled pen) for subcutaneous use. It treats diabetes mellitus in both type 1 and type 2 patients.
GNH USA supplies Liprolog Junior Kwikpen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Insulin Lispro used for?
Insulin Lispro is a rapid‑acting insulin analog used to manage blood glucose in diabetes mellitus.
- Type 1 diabetes mellitus: provides mealtime glucose control to reduce hyperglycemia. - Type 2 diabetes mellitus (as adjunct therapy): improves post‑prandial glucose levels when combined with oral agents. - Diabetes mellitus (general): offers rapid reduction of elevated blood glucose after meals.
What are the side effects of Insulin Lispro?
Common Side Effects: - Hypoglycemia (low blood sugar) - Injection site pain or erythema - Lipohypertrophy at injection sites - Mild allergic skin reactions
Serious or Rare Side Effects: - Severe hypoglycemia leading to loss of consciousness - Anaphylactic reaction - Edema - Hypersensitivity with bronchospasm
What precautions apply to Insulin Lispro?
Precautions should be taken when using Liprolog Junior Kwikpen. - Dose individualization: adjust based on blood glucose monitoring and carbohydrate intake. - Hypoglycemia risk: monitor for signs and have a rapid‑acting carbohydrate source available. - Renal impairment: may require dose reduction. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Drug interactions: review concomitant medications that affect glucose levels. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Insulin Lispro interact with?
Insulin Lispro may interact with several medicines.
Major Interactions (Avoid): - Concurrent use of sulfonylureas: increased hypoglycemia risk. - Beta‑blockers: may mask hypoglycemia symptoms. - Systemic corticosteroids: may require higher insulin dose.
Moderate Interactions (Monitor Closely): - ACE inhibitors: may enhance insulin sensitivity, monitor glucose. - Thiazide diuretics: may raise blood glucose, monitor levels. - Alcohol: can cause delayed hypoglycemia, advise caution.
Frequently asked questions
What is Liprolog Junior Kwikpen used for?+
How does insulin lispro work?+
What is the usual dose of Liprolog Junior Kwikpen?+
Is Liprolog Junior Kwikpen safe in pregnancy or breastfeeding?+
How do I order Liprolog Junior Kwikpen from GNH USA?+
How does Liprolog Junior Kwikpen compare with regular human insulin?+
What are the storage and handling requirements for Liprolog Junior Kwikpen?+
How is Liprolog Junior Kwikpen administered?+
What are the most serious risks to watch for when using Liprolog Junior Kwikpen?+
Who should not use Liprolog Junior Kwikpen?+
Product details
Related products

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo